Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 169 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

 		Idiopathic Inflammatory Myopathies Phase2 France
Germany
Israel
Japan
Singapore
United States
View All
 NCT06665256

A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

 		Primary Hypercholesterolemia, Mixed Dyslipidemia Phase4 India NCT06386419

Specified Drug-use Surveillance of Fabhalta Capsules

 		Paroxysmal Nocturnal Hemoglobinuria Japan NCT06606314

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

 		Relapsing Multiple Sclerosis Phase3 United States NCT03650114

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

 		Healthy Volunteers, Pulmonary Arterial Hypertension Phase1, Phase2 United States NCT06649110

An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).

 		Systemic Lupus Erythematosus, SLE Phase1 Bulgaria
Germany
Netherlands
Spain
View All
 NCT06335979

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

 		Sickle Cell Disease Phase3 United States NCT06439082

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

 		Amyotrophic Lateral Sclerosis (ALS) Phase2 United States NCT06643481

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

 		Spinal Muscular Atrophy (SMA) Greece
Ireland
Israel
Korea, Republic of
Poland
Portugal
Romania
Russian Federation
Taiwan
United States
View All
 NCT04174157

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

 		Atypical Hemolytic Uremic Syndrome Phase3 Austria
Brazil
China
Czechia
Greece
India
Japan
Korea, Republic of
Slovakia
Slovenia
Taiwan
United Kingdom
United States
View All
 NCT04889430